Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Invested Capital (2016 - 2026)

Avanos Medical's Invested Capital history spans 13 years, with the latest figure at $868.5 million for Q4 2025.

  • On a quarterly basis, Invested Capital fell 8.94% to $868.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $868.5 million, a 8.94% decrease, with the full-year FY2025 number at $868.5 million, down 8.94% from a year prior.
  • Invested Capital hit $868.5 million in Q4 2025 for Avanos Medical, roughly flat from $871.4 million in the prior quarter.
  • Over the last five years, Invested Capital for AVNS hit a ceiling of $1.9 billion in Q1 2022 and a floor of -$681.5 million in Q2 2025.
  • Historically, Invested Capital has averaged $1.0 billion across 5 years, with a median of $1.4 billion in 2021.
  • Biggest five-year swings in Invested Capital: surged 949.97% in 2024 and later tumbled 934.35% in 2025.
  • Tracing AVNS's Invested Capital over 5 years: stood at $1.4 billion in 2021, then rose by 8.35% to $1.5 billion in 2022, then decreased by 8.03% to $1.4 billion in 2023, then tumbled by 31.66% to $953.8 million in 2024, then fell by 8.94% to $868.5 million in 2025.
  • Business Quant data shows Invested Capital for AVNS at $868.5 million in Q4 2025, $871.4 million in Q3 2025, and -$681.5 million in Q2 2025.